US vaccine advisers abandon broad COVID shot support
A panel of US vaccine advisers said COVID-19 shots should be administered only through shared decision-making with a healthcare provider. The move sc…
More →
Bird flu vaccine: why countries have resisted it
With more than 200 million fowl deaths due to bird flu or mass culling since early last year, many governments around the world are considering vacci…
More →
New Jersey residents line up for monkeypox vaccine
A New Jersey community organization says demand for the monkeypox vaccine has been rising as the U.S. Centers for Disease Control and Prevention say …
More →
BioNTech to ship Omicron vaccines from October
BioNTech expects to begin deliveries of two Omicron-adapted vaccines as soon as October, which will help spur demand in the fourth-quarter, the Germa…
More →
FDA approves COVID vaccines for small children
Moderna and Pfizer-BioNTech's COVID vaccines have been authorized for children aged 5 and under by the U.S. Food and Drug Administration, opening…
More →
Which countries are offering vaccines for monkeypox?
As more countries where monkeypox is not endemic report outbreaks of the viral disease, some governments have started offering vaccines to most expos…
More →
Moderna says COVID shot for kids under six is safe
Moderna said it will ask the U.S. FDA and other regulators to authorize its COVID-19 vaccine in children younger than six years old based on data sho…
More →
South Africa's Aspen to supply COVID vaccine by June
South Africa's Aspen Pharmacare strikes deal with Johnson & Johnson to package, sell and distribute the American group's COVID vaccines u…
More →
COVAX delivers its 1 billionth COVID-19 vaccine dose
On 15 January 2021, a shipment of 1.1 million COVID-19 vaccines to Rwanda included the billionth dose supplied via COVAX.
More →
British study supports mixed vaccine regimens
A British study has found that switching up vaccines for the second dose can lead to a strong immune response, especially a shot of AstraZeneca or Pf…
More →
Pfizer/BioNTech seeking data on new COVID variant
BioNTech said it's expecting more data in the coming weeks on a worrying new COVID-19 variant first detected in South Africa, which would help de…
More →
Republican governors lead attack on Biden vaccine mandate
Republican governors began filing lawsuits on Friday to stop the Biden administration's requirement that nearly 2 million U.S. employers get work…
More →
WHO issues emergency use listing for eighth COVID-19 vaccine
The World Health Organization (WHO) issued an emergency use listing (EUL) for COVAXIN® (developed by Bharat Biotech), adding to a growing portfolio o…
More →
U.S. worker rebellion swells over vaccine mandate
In the U.S., a small but vocal group of employees is balking at a federally imposed vaccine mandate impacting companies doing business with the gover…
More →
Pfizer vaccine shows over 90% effective in children
The Pfizer/BioNTech COVID-19 vaccine showed 90.7% efficacy against the coronavirus in a clinical trial of children 5 to 11 years old, the U.S. drugma…
More →
U.S. FDA clears Moderna and J&J boosters
The U.S. Food and Drug Administration authorized booster doses of the COVID-19 vaccines from Moderna and Johnson & Johnson, and said Americans ca…
More →
FDA advisors back Johnson & Johnson booster for ages 18 and up
Outside advisers to the U.S. Food and Drug Administration voted unanimously to recommend regulators authorize a second shot of Johnson & Johnson&…
More →
J&J to seek U.S. authorization for booster
Johnson & Johnson plans to ask U.S. regulators to authorize a booster shot of its single-shot COVID-19 vaccine, according to a report by The New …
More →
Sanofi drops vaccine bid amid rivals' success
Sanofi has given up developing its own mRNA-based COVID-19 vaccine because of the dominant position of the BioNTech-Pfizer alliance.
More →
How the COVID-19 vaccines were created so quickly | TED
Discover how mRNA vaccines help your immune system fight viral infections and how this decades-old technology was used to create COVID-19 vaccines.
More →
Suscribirse a:
Entradas (Atom)
Follow us on social networks!